Spero Therapeutics, Inc.
SPRO· Nasdaq
Spero Therapeutics, Inc.
- Last sale
- Oct 2, 2026 · -4.80%
- Market cap
- $69.30M
- 58.23M shares
- Filings
- 513
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $12,586,000 | reported | |
| FY 2024 | 2024-12-31 | $371,000 | reported | |
| FY 2023 | 2023-12-31 | $933,000 | reported | |
| FY 2022 | 2022-12-31 | $2,503,000 | reported | |
| FY 2021 | 2021-12-31 | $3,070,000 | reported | |
| FY 2020 | 2020-12-31 | $258,000 | reported | |
| FY 2019 | 2019-12-31 | $4,742,000 | reported | |
| FY 2018 | 2018-12-31 | $3,966,000 | reported | |
| FY 2017 | 2017-12-31 | $1,979,000 | reported | |
| FY 2016 | 2016-12-31 | $335,000 | reported |
Spero Therapeutics, Inc. · CIK 1701108 · Engraved from SEC EDGAR
